Digital vs. Printed Package Inserts: The Numbers the Industry Needs to Know
Concrete data on costs, environmental impact, patient adherence, and legal risks comparing printed and digital package inserts.
The discussion about digital versus printed package inserts usually boils down to generic arguments about "modernization" and "sustainability." But when we analyze the real numbers, the difference between the two formats is far more dramatic than most pharmaceutical managers realize.
The hidden cost of printed inserts
The direct printing cost per insert is apparently low: between R$0.02 and R$0.08 per unit. But this number conceals a series of indirect costs that completely change the equation:
- Update cost: When ANVISA approves an insert change (which happens on average 2.3 times per year per medication), the entire stock of printed inserts becomes obsolete. For a laboratory with 100 medications and average production of 500,000 units/month, this can represent R$80,000 to R$300,000 in waste and reprinting per update.
- Logistics cost: Printed inserts take up storage space, require physical version control, and need to be manually inserted into packaging. Logistics costs represent 15% to 25% of total insert costs.
- Compliance cost: Maintaining traceability of which insert version accompanies each batch requires control systems that, in many labs, are still manual spreadsheets.
When we add all these costs, a mid-size laboratory spends between R$1.2 million and R$3.5 million per year on printed inserts alone. Digital inserts reduce this cost by 70% to 90% in the medium term.
Environmental impact: beyond the talking points
The Brazilian pharmaceutical industry consumes approximately 120,000 tons of paper per year for inserts alone. To put this in context: that is roughly 2 million trees cut per year, the production and disposal process emits about 360,000 metric tons of CO₂ equivalent, and the water consumed would be enough to supply a city of 200,000 inhabitants for a year.
Patient adherence: the clinical argument
The most impactful data point rarely appears in corporate discussions: printed inserts may be contributing to medication errors. A study published in the British Journal of Clinical Pharmacology showed that 43% of patients over 65 cannot read the printed insert for their medications, even with reading glasses.
Digital inserts with font adjustment, high contrast, and text-to-speech demonstrate 60% higher comprehension rates among elderly patients compared to printed inserts, according to research in European hospitals after e-PIL implementation.
Direct comparison
| Criteria | Printed Insert | Digital Insert |
|---|---|---|
| Cost per update | R$80k-300k (waste + reprint) | R$0 (instant update) |
| Update time | 4-8 weeks | Minutes |
| Accessibility (WCAG) | Does not comply | Level AA or higher |
| Text-to-speech | Impossible | Native (TTS) |
| Carbon footprint (per 1M units) | ~3 tons CO₂ | ~0.02 tons CO₂ |
Conclusion: a question of when, not if
With RDC 885/2024 in effect, migration to digital inserts is no longer optional. But even without the regulation, the economic, environmental, and clinical data already made this transition inevitable.